[{"address1": "Maxim 1", "address2": "2 Parklands Way Holytown", "city": "Motherwell", "zip": "ML1 4WR", "country": "United Kingdom", "phone": "44 14 1433 7557", "website": "https://tcbiopharm.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bryan Leland Kobel", "age": 44, "title": "CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 544560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin Edward Thorp", "age": 71, "title": "CFO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 410521, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Camarra", "title": "Executive Vice President of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lauren  Bor Ph.D.", "title": "Head of Commercial Development Division", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.34, "open": 5.51, "dayLow": 5.3, "dayHigh": 6.86, "regularMarketPreviousClose": 5.34, "regularMarketOpen": 5.51, "regularMarketDayLow": 5.3, "regularMarketDayHigh": 6.86, "beta": 0.08, "forwardPE": -1.2108697, "volume": 266390, "regularMarketVolume": 266390, "averageVolume": 78988, "averageVolume10days": 370210, "averageDailyVolume10Day": 370210, "bid": 4.87, "ask": 6.92, "bidSize": 200, "askSize": 200, "marketCap": 2887839, "fiftyTwoWeekLow": 2.11, "fiftyTwoWeekHigh": 1280.0, "fiftyDayAverage": 6.5577, "twoHundredDayAverage": 19.879925, "currency": "USD", "enterpriseValue": 551634624, "floatShares": 98357647, "sharesOutstanding": 518463, "sharesShort": 30240, "sharesShortPriorMonth": 3285, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0583, "heldPercentInsiders": 0.0002, "heldPercentInstitutions": 0.017690001, "shortRatio": 0.8, "shortPercentOfFloat": 0.061100002, "bookValue": 3.382, "priceToBook": 1.6469545, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -8593896, "trailingEps": -200.1, "forwardEps": -4.6, "enterpriseToEbitda": -42.684, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TCBP", "underlyingSymbol": "TCBP", "shortName": "TC BioPharm (Holdings) plc", "longName": "TC Biopharm (Holdings) Plc", "firstTradeDateEpochUtc": 1644589800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ef544858-646b-3e8d-bcb0-2aed3539a593", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.57, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 980955, "totalCashPerShare": 0.01, "ebitda": -12923699, "totalDebt": 1728127, "quickRatio": 0.459, "currentRatio": 0.882, "debtToEquity": 159.939, "returnOnAssets": -1.08915, "returnOnEquity": -12.1748, "freeCashflow": -6853025, "operatingCashflow": -10042216, "financialCurrency": "GBP", "trailingPegRatio": null, "__fetch_time": "2024-09-01"}]